Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Clinical trial NCT06448793 · COMPLETED

Trial details

NCT number: NCT06448793
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2024-11-25
Primary completion: 2025-10-31
Enrollment: 650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.